Otonomy to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

Rhea-AI Summary

Otonomy, Inc. (Nasdaq: OTIC) announced its participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference on November 22, 2021. The company will feature a pre-recorded fireside chat available from 10 a.m. ET / 7 a.m. PT. A link to the chat can be found on Otonomy's website. Additionally, Otonomy will hold one-on-one investor meetings on December 1, 2021, arranged exclusively through Piper Sandler. Otonomy focuses on developing innovative therapeutics for neurotology, particularly addressing hearing loss and tinnitus.

SAN DIEGO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference. Management will participate in a pre-recorded company fireside chat, which will be available on the conference website beginning at 10 a.m. ET / 7 a.m. PT on November 22, 2021.

A link to the fireside chat will also become available at the same time through the Events page of the company's website (www.otonomy.com).

Otonomy will be participating in 1x1 meetings with investors on Wednesday, December 1, and meetings can be requested exclusively via Piper Sandler.

About Otonomy

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs with a focus on hearing loss and tinnitus. For additional information please visit www.otonomy.com.

Contacts:

Media Inquiries:
Spectrum Science
Chloé-Anne Ramsey
Vice President
404.865.3601
cramsey@spectrumscience.com

Investor Inquiries:
Westwicke ICR
Robert H. Uhl
Managing Director
858.356.5932
robert.uhl@westwicke.com

FAQ

When is Otonomy participating in the Piper Sandler Healthcare Conference?

Otonomy will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference on November 22, 2021.

What time will Otonomy's fireside chat be available?

The fireside chat will be available starting at 10 a.m. ET / 7 a.m. PT on November 22, 2021.

How can I access Otonomy's fireside chat?

You can access the fireside chat through the Events page on Otonomy's website at www.otonomy.com.

When are Otonomy's one-on-one investor meetings scheduled?

Otonomy's one-on-one investor meetings are scheduled for December 1, 2021.

What is Otonomy's focus in biopharmaceuticals?

Otonomy is focused on developing therapeutics for neurotology, specifically targeting hearing loss and tinnitus.